PNCQ discloses the IFCC’s document - International Federation of Clinical Chemistry and Laboratory Medicine - about the assessment of the Glucose Meters in intensive care.

The IFCC-WG-GMECC Work Group concluded the document called: “How should we assess the Glucose Meters for critical attention?“, which addresses the clinical practice of using Glucose Meters in the blood (SMG) and what requirements must be met to be used in patients in a critical condition and also the attention of the physicians in patients with several health conditions and who receive intensive care intervention.

After the Food and Drug Administration of the United States (FDA) issued a provisional Guide, in 2014, about the monitoring systems of Glucose in blood for use in treatment, the members of the Group stated preoccupation about the accuracy and about the risks of using the Glucose Meters for patients with acute diseases. They don’t recommend the use of capillary blood for the Glucometers in patients with critical diseases or in medical treatment units. The option to control the Glucose levels for these patients includes the use of alternative instruments when using samples of arterial or venous blood.

The Group expects the document stimulates an active discussion about the multiple specialties in several health units and may improve the collaborative knowledge of better practices among the ones who may be interested, laboratory professionals, clinicians and equipment and reagent industries. The Group also expects the scientific societies discuss the theme for an evolution of the recommendations and practices for the present and future technologies, in favor of the patients’ safety.

At present a second document is being developed which addresses quality management and the recommendations of qualification and competence for the Glucose Meters.

IFCC’s Participants: Dr. Cyntia Bowman, President and editor of WG-GMECC’s documents, Department of Pathology of Baystate Health, Springfield, MA/USA; Sean Cunnigham, Member of WG-GMECC and assistant editor of documents, Clinical Biochemical Advisor (European Specialist in Laboratory Medicine EuspLM) Dublin, Ireland.

The original document is available here.

Published: 7/11/2018


Restricted Area